Horizon Pharma, Inc. — Moody's Publishes Covenant Quality Assessment for Horizon Pharma, Inc. / Horizon Pharma USA, Inc.

New York, October 16, 2016 — Moody’s Investors Service has assigned an overall covenant quality score of 4.39 to Horizon Pharma …
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
730